"We are pleased that the panel which was convened last week backed the animal studies to show effectiness, and we are cinfident in the test that raised FDA concerns and are working to help answer any linguring questions before the
mid-November deadline for an approval decision"

Peter Vozzo.

Looks like they are getting this done.